ATE198549T1 - Verwendung von dehydroepiandrosteron zur suchtbehandlung - Google Patents

Verwendung von dehydroepiandrosteron zur suchtbehandlung

Info

Publication number
ATE198549T1
ATE198549T1 AT97920642T AT97920642T ATE198549T1 AT E198549 T1 ATE198549 T1 AT E198549T1 AT 97920642 T AT97920642 T AT 97920642T AT 97920642 T AT97920642 T AT 97920642T AT E198549 T1 ATE198549 T1 AT E198549T1
Authority
AT
Austria
Prior art keywords
chemical
sex steroid
steroid precursor
addiction
dheas
Prior art date
Application number
AT97920642T
Other languages
English (en)
Inventor
Gerardus Joannes Emile Nefkens
Helga Manuela Noijen
Original Assignee
Gerardus Joannes Emile Nefkens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerardus Joannes Emile Nefkens filed Critical Gerardus Joannes Emile Nefkens
Application granted granted Critical
Publication of ATE198549T1 publication Critical patent/ATE198549T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT97920642T 1996-04-10 1997-04-10 Verwendung von dehydroepiandrosteron zur suchtbehandlung ATE198549T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1002833A NL1002833C2 (nl) 1996-04-10 1996-04-10 Werkwijze, voor duurzame ontwenning van/aan nicotine en andere verslavende producten door toediening van sex steroide voorlopers (precursors), alsmede het gebruik van die voorlopers als medicijn.
PCT/EP1997/001779 WO1997037663A1 (en) 1996-04-10 1997-04-10 Use of dehydroepiandrosterone for the treatment of addictions

Publications (1)

Publication Number Publication Date
ATE198549T1 true ATE198549T1 (de) 2001-01-15

Family

ID=19762655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920642T ATE198549T1 (de) 1996-04-10 1997-04-10 Verwendung von dehydroepiandrosteron zur suchtbehandlung

Country Status (8)

Country Link
US (1) US6194400B1 (de)
EP (1) EP0888116B1 (de)
AT (1) ATE198549T1 (de)
AU (1) AU2695297A (de)
DE (1) DE69703877T2 (de)
ES (1) ES2155685T3 (de)
NL (1) NL1002833C2 (de)
WO (1) WO1997037663A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US10912806B2 (en) 2018-09-26 2021-02-09 Michael MCGOWAN Composition comprising an essential oil and its packaging thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518595A (en) * 1983-07-19 1985-05-21 The Jackson Laboratory Method for treating diabetes using DHEA compounds

Also Published As

Publication number Publication date
EP0888116B1 (de) 2001-01-10
AU2695297A (en) 1997-10-29
NL1002833A1 (nl) 1996-08-12
NL1002833C2 (nl) 1997-04-03
DE69703877D1 (de) 2001-02-15
US6194400B1 (en) 2001-02-27
DE69703877T2 (de) 2001-08-16
ES2155685T3 (es) 2001-05-16
EP0888116A1 (de) 1999-01-07
WO1997037663A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
WO1999011250A3 (en) Noribogaine in the treatment of pain and drug addiction
AU622101B2 (en) Oral administration capsule with a nicotine-containing fluid medium
NZ515301A (en) Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
DE69737510D1 (de) Verwendung eines unverkapselten anti-krebs-wirkstoffs zur herstellung einer zubereitung zur behandlung von neoplasmen durch inhalation
ATE322283T1 (de) Transdermale verwendung von sekretin zur behandlung von autismus
DE69840495D1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
HK1076379A1 (en) Use of a composition comprising anti-vla-1 antibody for the preparation of a pharmaceutical composition for the treatment of pulmonary fibrosis
YU48559B (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
ATE241989T1 (de) Verwendung von aromatasehemmern zur herstellung eines arzneimittels zur behandlung eines relativen androgenmangels beim mann
DE69328635T2 (de) Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren
IL114296A (en) Use of melatonin in the manufacture of medicament for treating or preventing addiction to benzodiazepines pharmaceutical formulation for this purpose and process for making the formulation
DE69622162D1 (de) Hautbleichende dermatologische und/oder kosmetische zusammensetzung
ATE198549T1 (de) Verwendung von dehydroepiandrosteron zur suchtbehandlung
GR3030383T3 (en) Solution containing igf-1.
PL326499A1 (en) Transcutateous therapeutic system (tts) for administration of active substances used in treating narcotic dependence or drug addiction
JP2003518506A (ja) 精製蟾酥エキスを用いて勃起性陰萎を予防および治療するための薬剤組成物
DE19850517B4 (de) Verwendung eines wirkstoffhaltigen transdermalen therapeutischen Systems in einer Kombinationsbehandlung mit und ohne Ultraschall
NZ307601A (en) Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
JP2021080255A (ja) 勃起不全治療用薬剤、その製造方法及び勃起不全治療用器具
JPH11180889A (ja) 霊芝からの抽出成分を含有する皮膚炎治療用薬液
WO2001028578A3 (en) A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME
SU1666118A1 (ru) Способ лечени невралгии тройничного нерва
Larson et al. Omeprazole, a long-lasting inhibitor of gastric secretion
WO2004004681A1 (de) Kombinationstherapie und mittel zu seiner durchführung
DE69736955D1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties